HLA-DR15 is associated with lower age at onset in multiple sclerosis.
about
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosisGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisPolymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibilityMultiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients.Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population.Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?Gene variants of adhesion molecules act as modifiers of disease severity in MS.Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bands.DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing AllelePolymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.HLA-DRB1*15 influences the development of brain tissue damage in early PPMSConsiderations for subgroups and phenocopies in complex disease genetics.Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian PopulationModification of Multiple Sclerosis Phenotypes by African Ancestry at HLAGenetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patientsNo association between identified multiple sclerosis non-MHC risk loci and neuromyelitis optica.HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis.Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosisAre cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the United Kingdom?Genetic determinants of risk and progression in multiple sclerosis.Progress in multiple sclerosis genetics.The immunogenetics of multiple sclerosis: A comprehensive review.An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locusInvestigation of relationship between social capital and quality of life in multiple sclerosis patients.Genetics in multiple sclerosis: past and future perspectives.Class II HLA interactions modulate genetic risk for multiple sclerosis.Sex and gender issues in multiple sclerosis.Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset.HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.Age of onset in concordant twins and other relative pairs with multiple sclerosis.Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisPolyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic miceThe genetics of multiple sclerosis: an up-to-date review.Heterogeneity in multiple sclerosis: scratching the surface of a complex disease.Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.
P2860
Q24563911-70DD56ED-10EB-4AB1-BE92-F980E6581369Q24635370-7259D3FF-5B74-491E-AEB5-2F70634E1D1FQ28742974-5E780C3D-77BC-44C2-9166-2FC417021639Q30980357-5980FDE3-A640-4987-8710-24332CE0B1C9Q33284956-456DA96F-EAFB-466D-BD3B-F5BABFE56150Q33573841-69BDD115-34C1-4CE1-813F-BFB1702F3DBEQ33605178-C0635DEC-C4FE-4B13-B3A1-916AAD4DDB14Q33792114-968C0F0D-B69C-4449-B894-4A9FEEBB0EF6Q34170448-54FF65BC-68F2-431F-8F1E-7EA23A39844FQ34349507-5EDD099D-9935-4367-A284-FE0EBD991A2AQ34375802-93B57A2C-C696-4A7B-B510-DDD4FD93C75AQ34553785-068C6EE6-99AB-46F5-A02C-4536DA0A8709Q34971637-D6A787B7-8865-4C47-80DD-0DB469F888B7Q34979385-20005313-89CB-456A-9F13-3A793D410589Q35101408-13F38925-6993-45ED-B156-F007720CA914Q35149579-05AF96A1-FF89-42BF-B69B-5FB458B8C7BBQ35187912-99807CC5-9476-4CBC-9A6A-1C2020744CC1Q35465548-0358F17C-7178-47C0-A416-023217968C0AQ35470638-C3679A16-31C0-4AEF-9B23-B8BFF49A9867Q35487679-25930C68-436C-4516-AB1E-23CD18D60EFDQ35593455-D7BE39B7-9A60-45C3-9E57-DDDE32C1BE37Q35915818-1B6BD885-D2DC-4192-A32F-9119A987D33FQ36382352-4AB2C492-B390-48BC-BD94-C34E4E341EB5Q36394834-0AA91EB4-D8A5-4880-89BC-D9D15DE5E47EQ36693352-248A1F7A-F436-49B6-AB53-AEB222B5D9B1Q36780532-05337F68-12D6-4CBA-8DF5-B753E6208D01Q36785946-DB4C4087-A511-4D19-9015-6A0F37ABB555Q36920509-BAEE7135-1675-414E-A542-5C01ECCE2F41Q36999743-F86F13B8-99BE-47B7-A9D7-8D332FE996C7Q37129595-3291393C-D3C9-4637-818A-7DA26545CB14Q37151283-9F1D08D4-DCA1-41EB-8262-75BF7AE1EB0AQ37272954-72824D12-0FB0-42F9-B5E1-BEF43E8EC2EAQ37368046-011BDFEF-A8A0-4574-862A-E05666B3847DQ37475594-3849AAD1-C05D-4015-8121-1852F57A7630Q37590908-1AD3E327-771C-4C7A-AB36-EECBDAC24D70Q37883681-CB48A533-939F-40A2-803F-C570C9DF67EAQ38020959-01AFF075-2D2A-40F7-9333-3ED12AE1B74BQ41295973-07570689-0E43-4EA0-984B-32E08A7DC46BQ41816221-260D78D7-7830-49BF-BEF1-EE5A667DD263Q42930458-E6D9DB1D-4C13-4EF8-AD74-68A9C140F921
P2860
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@ast
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@en
type
label
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@ast
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@en
prefLabel
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@ast
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@en
P2093
P1433
P1476
HLA-DR15 is associated with lower age at onset in multiple sclerosis.
@en
P2093
P304
P356
10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I
P577
2000-08-01T00:00:00Z